AMAT vs MAZE · P/E 56, rev $24.04B vs rev $20.0M
Applied Materials Inc (AMAT) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the AMAT and MAZE stock pages for the full models.
Not investment advice.